October 28, 2003

Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02

Key Points

Key points are not available for this paper at this time.

Abstract

The RTOG 92-02 trial supports the addition of LT adjuvant AD to STAD with RT for T2c-4 PC. In the exploratory subset analysis of patients with Gleason scores 8 to 10, LT adjuvant AD resulted in a survival advantage.

Perguntar à IA

Bookmark

Cite This Study

Hanks et al. (Tue,) studied this question.

synapsesocial.com/papers/69d850d5f4e559c61eae36ff https://doi.org/https://doi.org/10.1200/jco.2003.11.023

Perguntar à IA

Bookmark